Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen A Rossi

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Journal of Computer-Aided Molecular Design|May 22, 2009
Closing the side-chain gap in protein loop modelingKaren A Rossi, Akbar Nayeem, Carolyn A Weigelt, et al.
Protein Science : a Publication of the Protein Society|July 31, 2007
Loopholes and missing links in protein modelingKaren A Rossi, Carolyn A Weigelt, Akbar Nayeem, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
5-Amidinobenzo[b]thiophenes as dual inhibitors of factors IXa and XaJennifer X Qiao, Xuhong Cheng, Dilip P Modi, et al.
Molecular Pharmacology|September 22, 2009
Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluationKeith J Miller, Ginger Y Wu, Jeffrey G Varnes, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent patternDavid A Nugiel, Anup Vidwans, Anna-Marie Etzkorn, et al.
Journal of Medicinal Chemistry|May 19, 2018
Factor XIa Inhibitors as New AnticoagulantsMimi L Quan, Donald J P Pinto, Joanne M Smallheer, et al.
Journal of Computer-Aided Molecular Design|August 3, 2005
Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitorsKaren A Rossi, Jay A Markwalder, Steven P Seitz, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor XaJohn M Fevig, Joseph Cacciola, Joseph Buriak, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Macrocyclic factor XIa inhibitorsCailan Wang, James R Corte, Karen A Rossi, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
5-Amidinoindoles as dual inhibitors of coagulation factors IXa and XaDouglas G Batt, Jennifer X Qiao, Dilip P Modi, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Journal of Computer-Aided Molecular Design|May 22, 2009
Closing the side-chain gap in protein loop modelingKaren A Rossi, Akbar Nayeem, Carolyn A Weigelt, et al.
Protein Science : a Publication of the Protein Society|July 31, 2007
Loopholes and missing links in protein modelingKaren A Rossi, Carolyn A Weigelt, Akbar Nayeem, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
5-Amidinobenzo[b]thiophenes as dual inhibitors of factors IXa and XaJennifer X Qiao, Xuhong Cheng, Dilip P Modi, et al.
Molecular Pharmacology|September 22, 2009
Position 5.46 of the serotonin 5-HT2A receptor contributes to a species-dependent variation for the 5-HT2C agonist (R)-9-ethyl-1,3,4,10b-tetrahydro-7-trifluoromethylpyrazino[2,1-a]isoindol-6(2H)-one: impact on selectivity and toxicological evaluationKeith J Miller, Ginger Y Wu, Jeffrey G Varnes, et al.
Journal of Medicinal Chemistry|November 15, 2002
Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent patternDavid A Nugiel, Anup Vidwans, Anna-Marie Etzkorn, et al.
Journal of Medicinal Chemistry|May 19, 2018
Factor XIa Inhibitors as New AnticoagulantsMimi L Quan, Donald J P Pinto, Joanne M Smallheer, et al.
Journal of Computer-Aided Molecular Design|August 3, 2005
Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitorsKaren A Rossi, Jay A Markwalder, Steven P Seitz, et al.
Bioorganic & Medicinal Chemistry Letters|May 10, 2006
Preparation of 1-(4-methoxyphenyl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective and bioavailable inhibitors of coagulation factor XaJohn M Fevig, Joseph Cacciola, Joseph Buriak, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Macrocyclic factor XIa inhibitorsCailan Wang, James R Corte, Karen A Rossi, et al.
Bioorganic & Medicinal Chemistry Letters|September 30, 2004
5-Amidinoindoles as dual inhibitors of coagulation factors IXa and XaDouglas G Batt, Jennifer X Qiao, Dilip P Modi, et al.
Pageof 5